2 results
Keyword Blinatumomab Remove keyword
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Orphan designations Remove Orphan designations filter
Medicine type
Orphan medicine Remove Orphan medicine filter
Orphan designation status
Positive Remove Positive filter
-
List item
Orphan designation: for: Treatment of acute lymphoblastic leukaemia
Date of first decision: 24/07/2009, Positive, Last updated: 08/12/2015opinion on orphan designation Blinatumomab for the treatment of acute … Micromet AG, Germany, for blinatumomab for the treatment of acute … information to show that blinatumomab might be of significant benefit … -
List item
Orphan designation: for: Treatment of B-cell acute lymphoblastic leukaemia
Date of first decision: 07/06/2013, Positive, Last updated: 25/06/2013